Novo Nordisk Secures Web Block On Ozempic Counterfeits
Novo Nordisk has convinced a London judge to block access to several websites selling counterfeit versions of its diabetes and weight loss drug Ozempic, after showing that the risks to public...To view the full article, register now.
Already a subscriber? Click here to view full article